complaint·September 18, 2024

Licensing Program Analyst (LPA) Michael Cava conducted a complaint visit to the facility to investigate the above allegation. It was reported that Resident 1 (R1) was given a double dose of their medication, because according to facility staff, it would help them to sleep better. LPA met with both administrators, Hayk Margaryan and Hovhannes Papazyan, and advised them of the complaint. Today's investigation consisted of interviews, a physical plant inspection and record review. Interviews with both administrators deny the allegation. Both administrators stated R1's physician increased the dosage of their medication by two for anxiety and insomnia. LPA conducted a record review, and observed a physician's order to increase their Lorazepam from one tablet orally per day to two tablets orally per day. Order date made was 08/24/24. Interviews with six (6) of six residents also deny the allegation. These residents did not express any complaints regarding their medications. Based on the information obtained, there wasn't enough evidence to prove staff overmedicated a resident. Therefore, the allegation is deemed Unusubsantiated at this time.